WPC
GILD icon

White Pine Capital’s Gilead Sciences GILD Stock Holding History

White Pine Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Sell
3,054
-10
-0.3% -$1.32K 0.09% 195
2026
Q1 		$427K Hold
3,064
– – 0.12% 179
2025
Q4 		$376K Buy
3,064
+81
+3% +$9.84K 0.1% 180
2025
Q3 		$331K Buy
2,983
+43
+1% +$4.89K 0.09% 192
2025
Q2 		$326K Buy
2,940
+535
+22% +$56.9K 0.1% 187
2025
Q1 		$269K Sell
2,405
-25
-1% -$2.58K 0.09% 200
2024
Q4 		$224K Buy
+2,430
New +$219K 0.08% 208

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

White Pine Capital's GILD Position: Q2 2026 in Review

White Pine Capital reduced its Gilead Sciences (GILD) stake by 0.33% in Q2 2026, selling an estimated $1.32K and leaving 3,054 shares worth $386K. The position accounts for 0.09% of the portfolio, ranked #195.

White Pine Capital first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $427K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • White Pine Capital held 3,054 shares of Gilead Sciences worth $386K as of Q2 2026.
  • White Pine Capital sold 10 Gilead Sciences shares in Q2 2026, an estimated $1.32K.
  • Gilead Sciences made up 0.09% of White Pine Capital's portfolio in Q2 2026, its #195 holding.
  • White Pine Capital first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • White Pine Capital's Gilead Sciences position peaked at $427K in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on White Pine Capital's 13F filing for Q2 2026, filed 5 Aug 2026.